Kuster Advocates for Granite State Seniors, Lowering Prescription Drug Costs in Energy and Commerce Committee with HHS Secretary Becerra
Washington, April 27, 2022
**The full Subcommittee hearing is available HERE**
**Rep. Kuster’s full remarks are available HERE**
Washington, D.C. — Today, Congresswoman Annie Kuster (NH-02), a senior member of the Energy and Commerce Health Subcommittee, participated in a hearing entitled, “The Fiscal Year 2023 HHS Budget." During the hearing, Rep. Kuster spoke directly with Health and Human Services Secretary Xavier Becerra about the Department’s priorities for the next year and the issues most important to Granite Staters, including expanding rural access to health care, lowering the cost of prescription drugs, and investing in our country’s care infrastructure.
“I consistently hear from Granite Staters across New Hampshire’s Second District about the rising costs of prescription drugs, something I am focused on addressing in Congress,” said Rep. Kuster. “Drug costs in the United States are on average 3 to 4 times higher than in other countries with comparable economies. This is unacceptable. I am pleased to see the Biden administration focusing on this issue and look forward to working with Secretary Becerra and the White House to get this done for communities in New Hampshire and across the country.”
Congresswoman Kuster is a strong voice for Granite Staters in Congress and a fierce advocate to improve our country’s health care system for all. Kuster’s Increasing Transparency in Generic Drug Applications Act would address a major barrier to generic drug approval and expedite patient access to affordable medicines by clarifying that FDA can provide generic drug applicants with improved directional guidance on their proposed formulation for complex generic drugs.